Targeted 5-HT1F Therapies for Migraine.

about

Migraine Therapy: Current Approaches and New Horizons.Emerging Therapies for Patients With Difficult-to-Treat Migraine Lasmiditan for the treatment of acute migraine: a review and potential role in clinical practice

P2860

Q52581504-3E0AEFD4-DB0A-4DDE-B7BC-B1BFF2E91425 Q57061242-07D935DA-4A4E-4D6B-A922-DFD699C35E2A Q57481750-18C6A47C-3C1E-465B-B1D5-A32EFABA9025

P2860

Targeted 5-HT1F Therapies for Migraine.

Item

http://www.wikidata.org/entity/Q52682101

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Targeted 5-HT1F Therapies for Migraine.

@en

Targeted 5-HT1F Therapies for Migraine.

@nl

type

Item

label

Targeted 5-HT1F Therapies for Migraine.

@en

Targeted 5-HT1F Therapies for Migraine.

@nl

prefLabel

Targeted 5-HT1F Therapies for Migraine.

@en

Targeted 5-HT1F Therapies for Migraine.

@nl

P1476

Targeted 5-HT1F Therapies for Migraine

@en

P2093

Marta Vila-Pueyo

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Cloning of another human serotonin receptor (5-HT1F): a fifth 5-HT1 receptor subtype coupled to the inhibition of adenylate cyclase

The 5-HT1F receptor agonist lasmiditan as a potential treatment of migraine attacks: a review of two placebo-controlled phase II trials

The pharmacological profile and clinical prospects of the oral 5-HT1F receptor agonist lasmiditan in the acute treatment of migraine

A review of central 5-HT receptors and their function

Isolation of a mouse "5HT1E-like" serotonin receptor expressed predominantly in hippocampus

Neurogenic inflammation and migraine: implications for the therapeutics

History of methysergide in migraine

5-HT2 receptor subtypes: a family re-united?

The International Classification of Headache Disorders, 3rd edition (beta version)

Possible antimigraine mechanisms of action of the 5HT1F receptor agonist LY334370.

P2888

s13311-018-0615-6

P304

291-303

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13311-018-0615-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Marta Vila-Pueyo

P5008

ScienceSource

P577

2018-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29488143

http://www.w3.org/2001/XMLSchema#string

P921

migraine disorder

carboxylic acid

amide

cell surface receptor

mechanism of action

membrane proteins

hydrocarbon

P932

5935644

http://www.w3.org/2001/XMLSchema#string

Targeted 5-HT1F Therapies for Migraine.

about

P2860

P2860

Targeted 5-HT1F Therapies for Migraine.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P2888

P304

P31

P356

P433

P478

P50

P5008

P577

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P2888

P304

P31

P356

P433

P478

P50

P5008

P577

P698

P921

P932